Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T15:06:05.490Z.
Calculation as of: 2026-10-06T15:06:05.490Z.
Quote observation: 2026-10-06T15:05:10.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d42caa3e816b0495fa2340ecfe28e9cd39b3fd8bb52e96b9f838481ccca068c7
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
C4 Therapeutics, Inc.
Market Cap
$324.51M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$328.56M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$320.29M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$332.58M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$338.14M
Operating Cash Flow Yield
N/A
TTM Avg
1.16%
3Y Avg
1.16%
5Y Avg
1.16%
Market Cap
$307.55M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$304.97M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$347.22M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$353.35M
Operating Cash Flow Yield
N/A
TTM Avg
3.39%
3Y Avg
3.76%
5Y Avg
5.04%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | $324.51M | N/A | N/A | N/A | N/A |
| Cabaletta Bio, Inc. (CABA)vs › | $328.56M | N/A | N/A | N/A | N/A |
| CapsoVision, Inc. (CV)vs › | $320.29M | N/A | N/A | N/A | N/A |
| ClearPoint Neuro, Inc. (CLPT)vs › | $332.58M | N/A | N/A | N/A | N/A |
| Agenus Inc. (AGEN)vs › | $338.14M | N/A | 1.16% | 1.16% | 1.16% |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $307.55M | N/A | N/A | N/A | N/A |
| Benitec Biopharma Inc. (BNTC)vs › | $304.97M | N/A | N/A | N/A | N/A |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $347.22M | N/A | N/A | N/A | N/A |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $353.35M | N/A | 3.39% | 3.76% | 5.04% |
| Opus Genetics, Inc. (IRD)vs › | $354.20M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
